NCT05054335

Brief Summary

This trial studies the development of patient-specific computational walking models to improve the surgical planning and rehabilitation treatment of patients with pelvic sarcomas. Every pelvis and pelvic sarcoma are different, and the orthopedic oncologist faces significant challenges when removing a tumor from the complex anatomy of the pelvis. These challenges make it difficult to achieve excellent oncological and functional outcomes together. Computational walking models may be used to predict the best combination of surgical methods and how to implement them to maximize each patient's post-surgery walking function.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for not_applicable

Timeline
20mo left

Started Jun 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress81%
Jun 2019Dec 2027

First Submitted

Initial submission to the registry

March 7, 2019

Completed
4 months until next milestone

Study Start

First participant enrolled

June 20, 2019

Completed
2.3 years until next milestone

First Posted

Study publicly available on registry

September 23, 2021

Completed
6.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 21, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 21, 2027

Last Updated

November 18, 2025

Status Verified

November 1, 2025

Enrollment Period

8.5 years

First QC Date

March 7, 2019

Last Update Submit

November 17, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • To establish the patient-specific computational models to inform surgical decisions and design custom implants that maximize post-surgery function.

    through study completion, an average of 1 year

Study Arms (2)

Supportive care (walking function test, X-ray)

EXPERIMENTAL

Patients undergo walking function assessment using optical motion capture and bi-plane dynamic X-ray imaging pre- and post-hemipelvectomy.

Other: Functional AssessmentProcedure: X-Ray Imaging

Retrospective Group

NO INTERVENTION

1. Acquisition of pre- and post-operative MRI data of the pelvic region (when available) collected previously as part of standard clinical care 2. Acquisition of pre-operative CT data of the pelvic region (when available) collected previously as part of standard clinical care 3. Acquisition of Physical Therapy Assessment data collected previously by a physical therapist and/or physical therapist assistant under protocol PA12-1046

Interventions

Undergo walking function assessment with optical motion capture

Supportive care (walking function test, X-ray)
X-Ray ImagingPROCEDURE

Undergo bi-plane dynamic X-ray imaging

Also known as: Conventional X-Ray, Diagnostic Radiology, Medical Imaging, X-Ray, Radiography, Static X-Ray, X-Ray
Supportive care (walking function test, X-ray)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who have received or are scheduled to receive an internal hemipelvectomy with or without reconstruction at UT MD Anderson Cancer Center.
  • Patients who are 18 years of age and older

You may not qualify if:

  • Patients who have undergone an external (hindquarter amputated), or an isolated type III internal hemipelvectomy.
  • Previous surgery or significant injury to either hip (prospective patients only)
  • Relevant surgery, procedure, injury, or condition in the last two years which may affect hip pain or general movement patterns on either side (prospective patients only)
  • Pregnant women or women nursing an infant
  • Persons with a pacemaker, hearing aid, aneurysm clips or artificial heart valves, and other forms of loose metal implants will be excluded from the study as assessed by a pre-MRI questionnaire administered by the MRI technician at the time of the scan.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

M D Anderson Cancer Center

Houston, Texas, 77030, United States

RECRUITING

Related Links

MeSH Terms

Interventions

X-Rays

Intervention Hierarchy (Ancestors)

Electromagnetic RadiationElectromagnetic PhenomenaMagnetic PhenomenaPhysical PhenomenaRadiationRadiation, Ionizing

Study Officials

  • Valerae O Lewis

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Valerae O Lewis, BS,MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 7, 2019

First Posted

September 23, 2021

Study Start

June 20, 2019

Primary Completion (Estimated)

December 21, 2027

Study Completion (Estimated)

December 21, 2027

Last Updated

November 18, 2025

Record last verified: 2025-11

Locations